SCHEMBL4436859

SCHEMBL4436859

OCc1cccn2c[c]nc12

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.33
HSD11B1 P28845 1/20 0.33
APOBEC3G Q9HC16 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4434358 0.82 GABRA1 (0.32)
SCHEMBL4435508 0.82 PNMT (0.31)
SCHEMBL15068507 0.72
SCHEMBL2315461 0.70 NUDT1 (0.41) NR1I2HSD11B1APOBEC3G
SCHEMBL18283243 0.68 NPC1 (0.41)
SCHEMBL4441329 0.68 NR1I2 (0.33) NR1I2HSD11B1
SCHEMBL2315975 0.67 NPC1 (0.38)
SCHEMBL25515799 0.66 APOBEC3G (0.38) APOBEC3G
SCHEMBL2313781 0.64 NPC1 (0.35) NR1I2HSD11B1
SCHEMBL2315424 0.64 ALDH1A3 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618981-B2 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide CYTOKINETICS, INC. (US) 2009-11-17 US claimed